0
Errata |

Correction to Dosage in Table 7: Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) FREE TO VIEW

Author and Funding Information

© 2011 American College of Chest Physicians


Chest. 2011;139(5):1261. doi:10.1378/chest.139.5.1261
Text Size: A A A
Published online

Corrected Legend: It has come to our attention that there was an incorrect dosage shown on p. 369S in Table 7 of the article, “Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition),” published in the June 2008 supplement of CHEST (2008;133(6)(Suppl):340S-380S). In the row labeled Bivalirudin under the Protocol column, the text “additional 0.1-0.5 mg boluses to maintain ACT > 2.5-fold baseline ACT” should be “additional 0.1-0.5 mg/kg boluses to maintain ACT > 2.5-fold baseline ACT.”


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543